Skip to main content
OpenTrials

Clinical trial condition

Hepatic Cirrhosis

Explore clinical trials studying Hepatic Cirrhosis. Study availability and eligibility vary by location and protocol.

27 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hepatic Cirrhosis trial results

Recruiting

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

NCT07610837

Conditions
Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +5 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Jupiter, Florida, United States
  • Research Site Miami, Florida, United States
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

NCT06750276

Conditions
Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +5 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Rialto, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Morehead City, North Carolina, United States
View Trial Details
Completed

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

NCT05904470

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +19 more
Locations
  • Atea Study Site San Antonio, Texas, United States
  • Atea Study Site Manaus, Amazonas, Brazil
  • Atea Study Site Salvador, Estado de Bahia, Brazil
  • Atea Study Site Brasília, Federal District, Brazil
View all 51 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

NCT06355479

Conditions
Blood Protein Disorders, Digestive System Diseases, Fibrosis, +9 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chongqing University Three Gorges Hospital Chongqing, Chongqing Municipality, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 37 locations
View Trial Details
Completed

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +9 more
Locations
  • North Alabama Health Research, LLC Madison, Alabama, United States
  • Local Institution - 0005 Chandler, Arizona, United States
  • Local Institution - 0088 Phoenix, Arizona, United States
  • Local Institution - 0006 Phoenix, Arizona, United States
View all 91 locations
View Trial Details
Completed

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

NCT03712280

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +14 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Inland Empire Clinical Trials Rialto, California, United States
  • Global Clinical Professionals St. Petersburg, Florida, United States
  • American Research Corporation at the Texas Liver Institute San Antonio, Texas, United States
View Trial Details

Related conditions